TNGX Reports $343M Cash, $343M Runway to 2028, Phase 1/2 Vopimetostat RAS Combos Data 2026
Tango Therapeutics, Inc. · PHARMACEUTICAL PREPARATIONS · Now $23.10
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS